These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7321447)

  • 21. Clinical effect of high doses of o-betahydroxyethyl-rutosides in patients with occlusive arterial disease.
    Bielawiec M; Lukjan H; Kiersnowska-Rogowska B; Dabrowski S
    Bibl Anat; 1979; (18):378-81. PubMed ID: 496871
    [No Abstract]   [Full Text] [Related]  

  • 22. [Urokinase in acute and chronic arterial diseases].
    Ciammaichella A; Gori M; Bonacci I
    Clin Ter; 1981 Nov; 99(4):377-81. PubMed ID: 7030591
    [No Abstract]   [Full Text] [Related]  

  • 23. [A new drug in the treatment of chronic arterial diseases of the limbs].
    Schmidt C; Royer RJ; Schmitt J
    Sem Hop; 1978 Feb; 54(4):210-3. PubMed ID: 208169
    [No Abstract]   [Full Text] [Related]  

  • 24. [Primary versus secondary femoro-femoral vascular reconstruction--effect of anticoagulation on long-term follow-up].
    Franke U; Wahlers T; Fieguth HG; Raygrotzki S; Borst HG
    Vasa Suppl; 1992; 35():117. PubMed ID: 1481012
    [No Abstract]   [Full Text] [Related]  

  • 25. [1st experiences with prostaglandin E1 long-term intra-arterial perfusion in advanced arterial occlusive disease of the lower extremities stage IV].
    Gruss JD; Kawai S; Karadedos C; Bartels D
    Dtsch Med Wochenschr; 1978 Oct; 103(41):1624-5. PubMed ID: 699778
    [No Abstract]   [Full Text] [Related]  

  • 26. [Discontinuation of oral anticoagulant therapy following fibrinolytic treatment in arterial occlusive disease].
    Engelken HJ; Martin M
    Med Welt; 1974 Jun; 25(25):1122-4. PubMed ID: 4418430
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
    Ionescu G; Pitea P; Blaj A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(3):207-13. PubMed ID: 2931752
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term results of prolonged dicoumarol anticoagulant therapy in 327 peipheral arteriopathic subjects].
    Papadia F; Ovaleo-Pandolfo E; Pampari GC; Marchesi G; Romano A; Pouché A
    Chir Ital; 1976 Dec; 28(6):817-30. PubMed ID: 70280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
    Ambrosi V; Gabrielli F
    Minerva Med; 1983 Mar; 74(13):685-9. PubMed ID: 6220230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Improvement of walking disability and conservative treatment. Guiding principles for drug treatment of chronic arterial occlusive disease (stage I and IIb)].
    Heinrich F
    Fortschr Med; 1984 Sep; 102(36):74-5. PubMed ID: 6489898
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment with mesoglycan of chronic obliterative atherosclerotic arteriopathies of the legs. Hematochemical and flowmetric changes].
    di Giovanna VN
    Clin Ter; 1988 Jun; 125(6):431-4. PubMed ID: 2973949
    [No Abstract]   [Full Text] [Related]  

  • 32. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
    Landini G; Poggiali C; Calacoci S; Marino N; Rosselli A
    Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V; Mammarella A; Alessandrini A; Barlattani M
    Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843
    [No Abstract]   [Full Text] [Related]  

  • 34. [Short-term and long-term results of treatment of chronic arteriopathies of the lower limbs with nicergoline. Importance of intensive medical therapy].
    Quiroli A
    Minerva Cardioangiol; 1980 Dec; 28(12):793-804. PubMed ID: 6111767
    [No Abstract]   [Full Text] [Related]  

  • 35. [State of the blood coagulating and fibrinolytic systems in arterial and venous diseases of the lower extremities].
    Shopov N; Mitov F; Manchev I; Argirov A
    Khirurgiia (Sofiia); 1977; 30(6):483-7. PubMed ID: 606930
    [No Abstract]   [Full Text] [Related]  

  • 36. [Detoxication therapy of patients with chronic occlusive arterial diseases of the lower extremities].
    Kungurtsev VV; Shimanko AI; Rybakov GS; Mnuskin DE; Sliun'kov VV
    Khirurgiia (Mosk); 1988 Dec; (12):8-11. PubMed ID: 3236724
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intra-arterial administration of a new synthetic prostacyclin in the treatment of gangrene of the legs].
    Ratto GB; Sacco A; Motta G
    G Chir; 1988 Feb; 9(2):110-1. PubMed ID: 2484802
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug therapy of peripheral arterial occlusive diseases in the lower extremities using Tebonin].
    Perinović M; Vasiljević M; Grujić M
    Ther Ggw; 1973 Mar; 112(3):434-6 passim. PubMed ID: 4700951
    [No Abstract]   [Full Text] [Related]  

  • 39. PGE1 treatment of severe skin ischemia in patients with peripheral arterial insufficiency--the effect on skin microcirculation.
    Fagrell B; Lundberg G; Olsson A; Ostergren J
    Vasa; 1986; 15(1):56-60. PubMed ID: 3962459
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
    Musil HE
    Med Welt; 1973 Jan; 24(3):103-13. PubMed ID: 4617835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.